Compass, Inc. shares rise 2.48% premarket after Compass Therapeutics announced a $120 million public offering.

Compass, Inc. rose 2.48% in premarket trading, with the company announcing the pricing of an underwritten public offering of 33,290,000 shares of its common stock at $3.00 per share and pre-funded warrants to purchase up to an aggregate of 6,710,000 shares of its common stock at $2.9999 per pre-funded warrant.